Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Pharma Bro ordered...

    Pharma Bro ordered jailed for online bounty on Hillary Clintons hair

    Written by Ruby Khatun Khatun Published On 2017-09-14T10:53:51+05:30  |  Updated On 14 Aug 2021 3:27 PM IST

    A U.S. judge on Wednesday ordered Martin Shkreli to be jailed while he awaits sentencing for securities fraud, citing a Facebook post in which the former drug company executive nicknamed the "Pharma Bro" offered a $5,000 reward for a strand of Hillary Clinton's hair.


    U.S. District Judge Kiyo Matsumoto in Brooklyn said the Sept. 4 post, which prompted a call from the U.S. Secret Service, showed Shkreli posed a danger to the public that warranted revoking his $5 million bails. U.S. prosecutors had moved to jail Shkreli last Thursday. Shkreli, who earned the nickname "Pharma Bro" for exploits that included increasing the price of a life-saving drug by 5,000 percent, apologized for the post in a letter to Matsumoto on Tuesday, calling it an "awkward attempt at humor or satire."


    Shkreli said in the post, since deleted, that he needed the hair to "confirm the sequences I have," an apparent reference to genetic testing.


    Shkreli was convicted in August of defrauding investors of two hedge funds he ran, MSMB Capital and MSMB Healthcare. He was acquitted of stealing from a drug company he later founded, Retrophin Inc, to pay them back.


    Though the charges carry a maximum sentence of 20 years, Shkreli will likely serve much less, in part because none of the investors lost money.


    Patients and U.S. lawmakers were outraged in 2015 when Shkreli, then chief executive of Turing Pharmaceuticals, raised the price of anti-infection drug Daraprim by 5,000 percent.


    Since his December 2015 arrest, he has clashed frequently with critics on social media. Twitter banned him from its platform in January for harassing a female journalist, another incident prosecutors cited in their motion to revoke his bail.


    (Reporting By Brendan Pierson in New York; Editing by David Gregorio)

    anti-infection drugbountyDaraprimhairHillary ClintonjailedJudge Kiyo Matsumotolife-saving drugsMartin ShkrelionlineorderedPharma BroRetrophin Incsecurities fraudTuring pharmaceuticals
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok